Kornitzer Capital Management’s West Pharmaceutical WST Stock Holding History

Kornitzer Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43M	Buy	+13,668	New	+$3.4M	0.07%	236
2025 Q3	–	Sell	-21,185	Closed	-$4.64M	–	533
2025 Q2	$4.64M	Hold	21,185	–	–	0.09%	243
2025 Q1	$4.74M	Sell	21,185 -147	-0.7%	-$40.5K	0.1%	233
2024 Q4	$6.99M	Sell	21,332 -2	-0%	-$629	0.14%	207
2024 Q3	$6.4M	Buy	21,334 +334	+2%	+$102K	0.12%	228
2024 Q2	$6.92M	Buy	+21,000	New	+$7.42M	0.13%	213
2019 Q1	–	Sell	-223,625	Closed	-$21.9M	–	496
2018 Q4	$21.9M	Buy	223,625 +1,610	+0.7%	+$175K	0.44%	82
2018 Q3	$27.4M	Buy	+222,015	New	+$24.9M	0.44%	83

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kornitzer Capital Management's WST Position: Q1 2026 in Review

Kornitzer Capital Management opened a new position in West Pharmaceutical (WST) in Q1 2026: 13,668 shares worth $3.43M. The stake represents 0.07% of the portfolio and ranks #236 among its holdings. This is a return to the name: Kornitzer Capital Management previously reported a position in WST as recently as Q2 2025.

Kornitzer Capital Management first reported a position in WST in Q3 2018 and has held it in 8 quarters since. The position peaked at $27.4M in Q3 2018. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Kornitzer Capital Management held 13,668 shares of West Pharmaceutical worth $3.43M as of Q1 2026.
West Pharmaceutical was a new Kornitzer Capital Management position in Q1 2026.
West Pharmaceutical made up 0.07% of Kornitzer Capital Management's portfolio in Q1 2026, its #236 holding.
Kornitzer Capital Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 8 quarters since.
Kornitzer Capital Management's West Pharmaceutical position peaked at $27.4M in Q3 2018.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Kornitzer Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.